Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)
In‐Ho Kim(The Catholic University of Korea Seoul St. Mary's Hospital), Soomin Ahn(Samsung Medical Center), Seung Joo Kang(Seoul National University Hospital), Jeong Il Yu(Samsung Medical Center), Choong‐kun Lee(Yonsei University), Wonyoung Choi(National Cancer Center), Kyoungjune Pak(Pusan National University Hospital), Tae-Han Kim(Changwon National University), Sang Soo Eom(Inje University Ilsan Paik Hospital), Jwa Hoon Kim(Korea University), Jae Seok Bae(Seoul National University Hospital), Sung Hak Lee(LG (United States)), Bang Wool Eom(National Cancer Center), Chung Hyun Tae(Ewha Womans University), Chang In Choi(Pusan National University Hospital), Nieun Seo(Yonsei University), Ho Jung An(The Catholic University of Korea St. Vincent's Hospital), Hyeon-Su Im(Ulsan College), Jae-Joon Kim(Korea University), Jeong Won Lee(Catholic Kwandong University), Soo Jin Kim(National Cancer Center), Sung Hee Lim(Bucheon University), Byung‐Hoon Min(Samsung Medical Center), Beodeul Kang(CHA University Bundang Medical Center), Hwa Kyung Byun(Yonsei University), Hye Sook Han(Chungbuk National University Hospital), Hyung‐Don Kim(Ulsan College), Jung Yoon Choi(Ansan University), An Na Seo(Kyungpook National University Medical Center), Oh Jeong(Chonnam National University), Bum Jun Kim(Korea University Medical Center), Miyoung Choi(National Evidenc- based healthcare Collaborating Agency), Jang Ho Cho(Gachon University Gil Medical Center)
Cited by 96
Related Papers
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
|Journal of the Korean Gastric Cancer Association|2023|285
2021 Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations
|Korean Journal of Radiology|2021|277
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
|The Lancet. Gastroenterology & hepatology|2024|245
Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity
|Clinical Cancer Research|2015|164